ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,363.36
1.81%
US Tech 100
18,164.80
1.78%
다우존스 지수
40,212.71
1.56%
Bitcoin
84,410.86
0.85%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Maravai LifeSciences Holdings Inc (MRVI) 시세

Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

NASDAQ
1.83
0.05
(2.81%)
마감 14 4월 5:00AM
15분 지연
1.83
0.01
(0.55%)
시간외 거래: 8:56AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
1.83
매수가
1.65
매도가
5.00
거래량
1,492,272
1.72 일간 변동폭 1.84
1.72 52주 범위 11.555
market_cap
465.435M
전일 종가
1.78
개장가
1.77
최근 거래 시간
1
@
1.78
마지막 거래 시간
재정 규모
US$ 2,644,642
VWAP
1.7722
평균 볼륨(3m)
3,492,518
발행 주식
254,335,883
배당수익률
-
주가수익률
-3.20
주당순이익(EPS)
-0.57
매출
262.4M
순이익
-144.85M

Maravai LifeSciences Holdings Inc 정보

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Wilmington, Delaware, USA
설립됨
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker MRVI. The last closing price for Maravai LifeSciences was US$1.78. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 1.72 to US$ 11.555.

Maravai LifeSciences currently has 254,335,883 shares in issue. The market capitalisation of Maravai LifeSciences is US$452.72 million. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -3.20.

MRVI 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
21 3월 2025
MRVI (2.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 3월 2025
MRVI (2.81%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.23-11.16504854372.062.151.7232744231.90229787CS
4-0.55-23.10924369752.382.711.7237721672.23291404CS
12-2.77-60.21739130434.66.051.7234925183.14080717CS
26-5.81-76.04712041887.648.5351.7226374304.17977057CS
52-6.86-78.94131185278.6911.5551.7223356336.15024389CS
156-34.87-95.013623978236.738.241.72218357410.92828469CS
260-29.28-94.117647058831.1163.551.72200169617.77531894CS

MRVI - Frequently Asked Questions (FAQ)

What is the current Maravai LifeSciences share price?
The current share price of Maravai LifeSciences is US$ 1.83
How many Maravai LifeSciences shares are in issue?
Maravai LifeSciences has 254,335,883 shares in issue
What is the market cap of Maravai LifeSciences?
The market capitalisation of Maravai LifeSciences is USD 452.72M
What is the 1 year trading range for Maravai LifeSciences share price?
Maravai LifeSciences has traded in the range of US$ 1.72 to US$ 11.555 during the past year
What is the PE ratio of Maravai LifeSciences?
The price to earnings ratio of Maravai LifeSciences is -3.2
What is the cash to sales ratio of Maravai LifeSciences?
The cash to sales ratio of Maravai LifeSciences is 1.76
What is the reporting currency for Maravai LifeSciences?
Maravai LifeSciences reports financial results in USD
What is the latest annual turnover for Maravai LifeSciences?
The latest annual turnover of Maravai LifeSciences is USD 262.4M
What is the latest annual profit for Maravai LifeSciences?
The latest annual profit of Maravai LifeSciences is USD -144.85M
What is the registered address of Maravai LifeSciences?
The registered address for Maravai LifeSciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Maravai LifeSciences operate in?
Maravai LifeSciences operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSPRMSP Recovery Inc
US$ 2.479
(93.67%)
85.68M
PRTGPortage Biotech Inc
US$ 8.5091
(66.85%)
29.09M
WTOUTime Limited
US$ 2.15
(61.65%)
1.19M
BFRGBullfrog AI Holdings Inc
US$ 2.09
(48.23%)
13.75M
THTXTheratechnologies Inc
US$ 1.94
(45.86%)
48.09M
MBMasterBeef Group
US$ 3.30
(-90.95%)
2.46M
ATHRAether Holdings Inc
US$ 5.5102
(-87.75%)
581.85k
TOROVToro Corporation
US$ 1.43
(-82.48%)
109.19k
LUCYInnovative Eyewear Inc
US$ 2.3471
(-52.58%)
1.95M
XHGXChange TED Inc
US$ 0.1985
(-45.71%)
8.09M
DMNDamon Inc
US$ 0.003
(-28.57%)
1.08B
BONBon Natural Life Ltd
US$ 0.066
(8.73%)
658M
STSSSharps Technology Inc
US$ 0.0245
(33.88%)
653.02M
NVDANVIDIA Corporation
US$ 110.93
(3.12%)
313.46M
LGMKLogicMark Inc
US$ 0.009699
(3.18%)
264.71M

MRVI Discussion

게시물 보기
Monksdream Monksdream 1 년 전
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 1 년 전
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

최근 히스토리

NASDAQ
MRVI
Maravai LifeSciences
NASDAQ
QADI
NASDAQ
FBZUX
Algonquin Fixed Income 2...
LSE
19VH
Sg Issuer 30
TSX
HCG
Home Capital
LSE
QJ15
Morg.st.b.v 24
LSE
BW52
Sw.fin.40
COIN
CRPTUSD
Crypterium
TG
NOEJ
NORMA
LSE
62WF
Sg Issuer 29
COIN
HTMLUSD
TG
7BC0
Forte
COIN
GNBTUSD
GENEBANK Token
LSE
75JA
Sant Uk. 25
LSE
AQ37
Int.agri.dev 29
NASDAQ
ARQQW
Arqit Quantum
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지